Dpysl5-KO 基因敲除小鼠

1. Kaarijärvi, Roosa, Kaljunen, Heidi, Nappi, Lucia, Hiltunen, Mikko, Ketola, Kirsi. 2024. DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2. In Communications biology, 7, 108. doi:10.1038/s42003-023-05741-x. https://pubmed.ncbi.nlm.nih.gov/38238517/

2. Jeanne, Médéric, Demory, Hélène, Moutal, Aubin, Toutain, Annick, Laumonnier, Frédéric. 2021. Missense variants in DPYSL5 cause a neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities. In American journal of human genetics, 108, 951-961. doi:10.1016/j.ajhg.2021.04.004. https://pubmed.ncbi.nlm.nih.gov/33894126/

3. Desprez, Florence, Ung, Dévina C, Vourc'h, Patrick, Jeanne, Médéric, Laumonnier, Frédéric. 2023. Contribution of the dihydropyrimidinase-like proteins family in synaptic physiology and in neurodevelopmental disorders. In Frontiers in neuroscience, 17, 1154446. doi:10.3389/fnins.2023.1154446. https://pubmed.ncbi.nlm.nih.gov/37144098/

4. Neri, Sabrina, Maia, Nuno, Fortuna, Ana M, Møller, Rikke S, Bayat, Allan. 2022. Expanding the pre- and postnatal phenotype of WASHC5 and CCDC22 -related Ritscher-Schinzel syndromes. In European journal of medical genetics, 65, 104624. doi:10.1016/j.ejmg.2022.104624. https://pubmed.ncbi.nlm.nih.gov/36130690/